Prosecution Insights
Prosecution Insights
56 pending office actions • 22 art units • 50 examiners • 0 of 56 (0%) have an AI response strategy ready • 74 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 4 (7%) |
| §103 only | 13 (23%) |
| §102 only | 2 (4%) |
| §112 only | 3 (5%) |
| Double-patenting only | 3 (5%) |
| Double-patenting + other | 9 (16%) |
| Multi-statute (no §101) | 21 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRADLEY, CHRISTINA | 2 | 62.9% | +33.0% |
| ULSH, DUNG T | 2 | 78.6% | +16.7% |
| THOMAN, EVELYN ANNE | 2 | — | — |
| DARB, HAMZA A. | 2 | 74.4% | +31.3% |
| BALLARD, KIMBERLY | 2 | 53.9% | +48.3% |
| REYNOLDS, FRED H | 2 | 33.1% | +39.0% |
| STEELE, AMBER D | 1 | 59.0% | +9.7% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| JACKSON, SHAWQUIA | 1 | 77.9% | -3.3% |
| PYLE, SIENNA CHRISTINE | 1 | 70.2% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18011965 | PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42 | WANG, CHANG YU | 32d overdue |
| 18312653 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ALDARONDO, DASIA ALI | 30d overdue |
| 17619289 | SYSTEMS AND METHODS FOR DETECTING MISSED BOLUS DOSES | PLAYER, ROBERT AUSTIN | 30d overdue |
| 18523645 | THERAPEUTIC USES OF DULAGLUTIDE | BEANE, RANDALL L | 29d overdue |
| 17211163 | COMBINATION THERAPY | BALLARD, KIMBERLY | 10d overdue |
| 18260125 | ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 3d overdue |
| 17433795 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | DARB, HAMZA A. | 2d overdue |
| 18176844 | THERAPEUTIC ANTIBODY FORMULATION | KIM, YUNSOO | 8d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17211163 | COMBINATION THERAPY | BALLARD, KIMBERLY | 10d overdue |
| 17433795 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | DARB, HAMZA A. | 2d overdue |
| 18044618 | DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDS | DARB, HAMZA A. | 14d |
| 17633631 | METHODS OF MAKING INCRETIN ANALOGS | REYNOLDS, FRED H | 28d |
| 19341996 | PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | BRADLEY, CHRISTINA | — |
| 19338984 | PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | BRADLEY, CHRISTINA | — |
| 18853699 | PROCESS FOR MAKING A KRAS G12C INHIBITOR | BARSKY, JARED | — |
| 18847285 | CAPSULE FOR GASTROINTESTINAL SAMPLING | PYLE, SIENNA CHRISTINE | — |
| Art Unit | Apps |
|---|---|
| 3783 | 9 |
| 1654 | 6 |
| 1658 | 4 |
| 1641 | 4 |
| 1675 | 3 |
| 1628 | 2 |
| 1674 | 2 |
| 1647 | 2 |
| 3686 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19351688 | PROCESSES AND INTERMEDIATES FOR PREPARING TIRZEPATIDE | STEELE, AMBER D | 1658 | §103DP | Final Rejection | — | Pending | Oct 07, 2025 |
| 19341996 | PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | BRADLEY, CHRISTINA | 1654 | §103§112 | Final Rejection | — | Pending | Sep 26, 2025 |
| 19338984 | PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | BRADLEY, CHRISTINA | 1654 | §103 | Non-Final OA | — | Pending | Sep 24, 2025 |
| 18853699 | PROCESS FOR MAKING A KRAS G12C INHIBITOR | BARSKY, JARED | — | DP | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18897646 | KRAS INHIBITORS | JACKSON, SHAWQUIA | — | §103DP | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18847285 | CAPSULE FOR GASTROINTESTINAL SAMPLING | PYLE, SIENNA CHRISTINE | — | §103 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18826275 | AT2R ANTAGONISTS AND USES THEREOF | ISMAIL, REHANA | — | DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18802006 | THREE RESIN REACTORS IN SERIES PEPTIDE SYNTHESIZER | AUDET, MAURY A | 1654 | §103DP | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18745159 | MEDICATION DELIVERY DEVICE WITH GEAR SET DOSAGE SYSTEM | MENDEZ, MANUEL A | — | §103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18713758 | SYSTEMS AND METHODS FOR IDENTIFYING SUBJECTS FOR CLINICAL TRIALS | HEIN, DEVIN C | 3686 | §101 | Final Rejection | 33d | Pending | May 28, 2024 |
| 18707780 | DEUTERATED (TRIFLUOROMETHYL)PYRIMIDINE-2-AMINE COMPOUNDS AS POTENTIATORS OF THE HMRGX1 RECEPTOR | HEES, OLIVER DRAGON | 1628 | §101§112DP | Non-Final OA | — | Pending | May 06, 2024 |
| 18699114 | STABILIZER FOR MEDICATION DELIVERY DEVICE | PONTON, JAMES D | — | §112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18697788 | INSERTER DEVICES INCLUDING REUSABLE AND DISPOSABLE PORTIONS | TURKOWSKI, KAYLA MARIE | — | §102§112 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18697785 | INSERTER DEVICES PROVIDING MANUAL INSERTION AND AUTOMATIC RETRACTION | RITCHIE, HADEN MATTHEW | — | §102 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18595872 | CONNECTED INJECTION DEVICES WITH STATUS SENSING SYSTEMS | VARGAS, ANNA ELIZABETH | 3783 | §102 | Non-Final OA | 70d | Pending | Mar 05, 2024 |
| 18588048 | DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE | ULSH, DUNG T | — | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18684061 | THERAPEUTIC AGENT DELIVERY DEVICE WITH USER INPUT | THOMAN, EVELYN ANNE | — | §103§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18409277 | THERAPEUTIC USES OF DULAGLUTIDE | CHANDRA, GYAN | 1674 | §102§103DP | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18571825 | COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS | RODRIGUEZ, CRIS LOIREN | 3783 | §103 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18523645 | THERAPEUTIC USES OF DULAGLUTIDE | BEANE, RANDALL L | 1654 | §102§103 | Final Rejection | 29d overdue | Pending | Nov 29, 2023 |
| 18565484 | METHOD FOR TREATING IDH INHIBITOR-RESISTANT SUBJECTS | O DELL, DAVID K | 1621 | §102§103DPOther | Non-Final OA | 61d | Pending | Nov 29, 2023 |
| 18509779 | MEDICATION DELIVERY DEVICE WITH A SENSED ELEMENT | ULSH, DUNG T | 3783 | §102§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18288314 | SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS | NOLAN, JASON MICHAEL | 1623 | §103 | Non-Final OA | 8d overdue | Pending | Oct 25, 2023 |
| 18552897 | TABLET DISPENSER | RANDALL, JR., KELVIN L | 3651 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18547460 | SELF-ASPIRATING SYRINGE SYSTEMS, CARTRIDGES, AND METHODS | AHMED, TASNIM M | 3783 | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18366061 | TRANSFERRIN RECEPTOR BINDING PROTEINS AND CONJUGATES | TAYLOR, LIA ELAN | 1641 | §101§112DP | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18260125 | ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 1641 | §103§112Other | Non-Final OA | 3d overdue | Pending | Jun 30, 2023 |
| 18259500 | HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME | KATAKAM, SUDHAKAR | 1658 | §112 | Final Rejection | 26d | Pending | Jun 27, 2023 |
| 18258018 | HUB FOR REUSABLE DRUG-DELIVERY DEVICE | ACKUN, JACOB K | 3783 | §103 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18257487 | FLUID DELIVERY SYSTEM WITH NEEDLE ASSEMBLY | THOMAN, EVELYN ANNE | 3783 | §103§112 | Non-Final OA | 83d | Pending | Jun 14, 2023 |
| 18266706 | METHODS OF TREATING DIABETES | HELLMAN, KRISTINA M | 1654 | §103§112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18266717 | METHODS OF TREATING DIABETES | YANG, TIAN | 1674 | §112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18312653 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ALDARONDO, DASIA ALI | 1647 | §103§112Other | Non-Final OA | 30d overdue | Pending | May 05, 2023 |
| 18297099 | COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 | NICKOL, GARY B | 1643 | DPOther | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | CHHAY, BONIRATH | 1645 | §103 | Final Rejection | 3d overdue | Pending | Mar 29, 2023 |
| 18247198 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN ANTIBODY PURIFICATION PROCESSES AND ANTIBODY COMPOSITIONS HAVING REDUCED HOST CELL PROTEIN CONTENT | SZPERKA, MICHAEL EDWARD | 1641 | §103§112DP | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18025586 | IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER | GAO, ASHLEY HARTMAN | 1678 | §103§112Other | Non-Final OA | — | Pending | Mar 09, 2023 |
| 18044618 | DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDS | DARB, HAMZA A. | 3783 | §102§103 | Non-Final OA | 14d | Pending | Mar 09, 2023 |
| 18176844 | THERAPEUTIC ANTIBODY FORMULATION | KIM, YUNSOO | 1641 | §103§112Other | Non-Final OA | 8d | Pending | Mar 01, 2023 |
| 17787015 | ENDOTOXIN DETECTION | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | 118d overdue | Pending | Feb 06, 2023 |
| 18040282 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | SCHMIDT, EMILY LOUISE | 3783 | §103 | Final Rejection | — | Pending | Feb 02, 2023 |
| 18005245 | LOW DOSE REGIMEN AND FORMULATION OF A 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUND | MOU, LIYUAN | 1628 | §103§112Other | Final Rejection | 34d | Pending | Jan 12, 2023 |
| 18011965 | PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42 | WANG, CHANG YU | 1675 | §102§103§112Other | Non-Final OA | 32d overdue | Pending | Dec 21, 2022 |
| 18054284 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODIES | ALLEN, MARIANNE P | 1647 | §112DP | Final Rejection | 139d overdue | Pending | Nov 10, 2022 |
| 17906580 | FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE | BURKETT, DANIEL JOHN | 1624 | DP | Non-Final OA | 9d overdue | Pending | Sep 16, 2022 |
| 17795797 | THERAPEUTIC USES OF DULAGLUTIDE | HA, JULIE | 1654 | §103 | Non-Final OA | — | Pending | Jul 27, 2022 |
| 17846636 | NOVEL RNA THERAPEUTICS AND USES THEREOF | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 111d overdue | Pending | Jun 22, 2022 |
| 17711099 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | BALLARD, KIMBERLY | 1649 | §103§112DP | Non-Final OA | — | Pending | Apr 01, 2022 |
| 17633631 | METHODS OF MAKING INCRETIN ANALOGS | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | 28d | Pending | Feb 08, 2022 |
| 17625180 | METHOD AND SYSTEM FOR DETERMINING GLUCOSE CHANGE IN A SUBJECT | SANFORD, DIANA PATRICIA | 1687 | §101§103 | Final Rejection | — | Pending | Jan 06, 2022 |
| 17554713 | Anti-CGRP Antibody Formulation | BORGEEST, CHRISTINA M | 1675 | §103Other | Non-Final OA | 4d overdue | Pending | Dec 17, 2021 |
| 17619289 | SYSTEMS AND METHODS FOR DETECTING MISSED BOLUS DOSES | PLAYER, ROBERT AUSTIN | 1686 | §101§103 | Non-Final OA | 30d overdue | Pending | Dec 15, 2021 |
| 17507414 | METHODS OF TREATING CROHN'S DISEASE | GUSTILO, ESTELLA M | 1646 | §103§112Other | Non-Final OA | — | Pending | Oct 21, 2021 |
| 17438692 | PRESERVED FORMULATIONS | REYNOLDS, FRED H | 1658 | §103§112Other | Non-Final OA | — | Pending | Sep 13, 2021 |
| 17433795 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | DARB, HAMZA A. | 3783 | §102§103 | Final Rejection | 2d overdue | Pending | Aug 25, 2021 |
| 17211163 | COMBINATION THERAPY | BALLARD, KIMBERLY | 1675 | §102§103§112 | Non-Final OA | 10d overdue | Pending | Mar 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial